To examine this possibility, we utilized two siRNAs (siRNA 1 and siRNA 2) specific for different regions of the RACK1 mRNA to knockdown RACK1 expression in mock and MRV infected normoxic and hypoxic tumor cells. The gene discussed is RACK1; the disease is neoplasm.